Home/Filings/4/0001104659-23-129365
4//SEC Filing

Birx Deborah 4

Accession 0001104659-23-129365

CIK 0000921114other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 9:53 PM ET

Size

7.1 KB

Accession

0001104659-23-129365

Insider Transaction Report

Form 4
Period: 2023-12-21
Birx Deborah
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-12-21+200,000200,000 total
  • Award

    Stock Options (Right to Buy)

    2023-12-21+200,000200,000 total
    Exercise: $2.39Exp: 2033-12-21Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the Stock Options shall vest on July 10th of each of 2024, 2025, 2026, and 2027.

Issuer

Armata Pharmaceuticals, Inc.

CIK 0000921114

Entity typeother

Related Parties

1
  • filerCIK 0001849673

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 9:53 PM ET
Size
7.1 KB